These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 8070314)

  • 21. The influence of dietary fat on hepatic bioactivation of aflatoxin B1 in rats.
    Hasler JA; Dube N; Nyathi CB; Fuhrmann H; Sallmann HP
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):279-87. PubMed ID: 8008977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
    Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE
    Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
    Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
    Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems.
    Neal GE; Eaton DL; Judah DJ; Verma A
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):152-8. PubMed ID: 9705898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats.
    Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D
    Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro biotransformation of aflatoxin B1 (AFB1) in channel catfish liver.
    Gallagher EP; Eaton DL
    Toxicol Appl Pharmacol; 1995 May; 132(1):82-90. PubMed ID: 7747288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.
    Manson MM; Ball HW; Barrett MC; Clark HL; Judah DJ; Williamson G; Neal GE
    Carcinogenesis; 1997 Sep; 18(9):1729-38. PubMed ID: 9328168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
    Miller NE; Halpert JR
    Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetics of aflatoxin B1 metabolism. Association of the induction of aflatoxin B1-4-hydroxylase with the transcriptional activation of cytochrome P3-450 gene.
    Koser PL; Faletto MB; Maccubbin AE; Gurtoo HL
    J Biol Chem; 1988 Sep; 263(25):12584-95. PubMed ID: 3137229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary modification of aflatoxin B1 carcinogenesis: mechanism studies with isolated hepatocytes from rainbow trout.
    Bailey GS; Taylor MJ; Loveland PM; Wilcox JS; Sinnhuber RO; Selivonchick DP
    Natl Cancer Inst Monogr; 1984 May; 65():379-85. PubMed ID: 6431290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
    Hayes JD; Judah DJ; Neal GE
    Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
    Guarisco JA; Hall JO; Coulombe RA
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
    Jhee EC; Ho LL; Lotlikar PD
    Cancer Res; 1988 May; 48(10):2688-92. PubMed ID: 3129185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of anti-carcinogenesis by indole-3-carbinol: effect on the distribution and metabolism of aflatoxin B1 in rainbow trout.
    Goeger DE; Shelton DW; Hendricks JD; Bailey GS
    Carcinogenesis; 1986 Dec; 7(12):2025-31. PubMed ID: 3096588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of beta-naphthoflavone on the metabolism of aflatoxin B1 in hamsters.
    Santhanam K; Lotlikar PD
    Cancer Lett; 1989 May; 45(2):129-34. PubMed ID: 2499415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
    Raina V; Williams CJ; Gurtoo HL
    Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methoxyindole-3-carbinol is a more efficient inducer of cytochrome P-450 1A1 in cultured cells than indol-3-carbinol.
    Stephensen PU; Bonnesen C; Schaldach C; Andersen O; Bjeldanes LF; Vang O
    Nutr Cancer; 2000; 36(1):112-21. PubMed ID: 10798223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
    Ramsdell HS; Eaton DL
    Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promotion of aflatoxin B1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency.
    Dashwood RH; Fong AT; Williams DE; Hendricks JD; Bailey GS
    Cancer Res; 1991 May; 51(9):2362-5. PubMed ID: 1901761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.